Severe Alcoholic Hepatitis Clinical Trial
Official title:
Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis
This study aimed to investigate the effect of decontamination by rifaximin in severe alcoholic hepatitis patients. Patients who take corticosteroid or pentoxifylline will be randomly allocated to rifaximin group or control group.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04106518 -
Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
|
||
| Not yet recruiting |
NCT06155760 -
Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis
|
N/A | |
| Completed |
NCT02808663 -
Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis
|
N/A | |
| Completed |
NCT01820208 -
Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis
|
N/A | |
| Withdrawn |
NCT03087968 -
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
|
Early Phase 1 | |
| Recruiting |
NCT03827772 -
Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis- Assessment of Impact on Prognosis and Short-term Outcome
|
N/A | |
| Completed |
NCT01801332 -
Intensive Enteral Nutrition and Acute Alcoholic Hepatitis
|
N/A | |
| Recruiting |
NCT04103840 -
Invasive Fungal Infections in Severe Alcohol-associated Hepatitis
|
||
| Active, not recruiting |
NCT03091010 -
A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.
|
N/A | |
| Completed |
NCT02161653 -
Metadoxine as a Therapy for Severe Alcoholic Hepatitis
|
Phase 4 |